Changes in beliefs about medications during long-term care for ischemic heart disease

American Heart Journal

Volumn 159, Issue 4, 2010, Pages 561-569

  Allen LaPointe, Nancy M ^a   Ou, Fang Shu ^a   Calvert, Sara B ^a   Melloni, Chiara ^a   Stafford, Judith A ^a   Harding, Tina ^a   Alexander, Karen P ^a   Peterson, Eric D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIOLOGIST; CONTROLLED STUDY; DEPRESSION; FEMALE; FOLLOW UP; HEALTH SURVEY; HOSPITAL; HOSPITAL DISCHARGE; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PERCEPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RELIABILITY; TOTAL QUALITY MANAGEMENT; VALIDITY;

AGED; ATTITUDE TO HEALTH; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PATIENT COMPLIANCE; TIME FACTORS;

EID: 77950123040     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.12.025     Document Type: Article

References (26)

1. Ho P.M., Spertus J.A., Masoudi F.A., et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med (2006) 1842-1847
2. Newby L.K., LaPointe N.M., Chen A.Y., et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation (2006) 203-212
3. Allen LaPointe N.M., Zhou Y., Stafford J.A., et al. Association between mortality and persistent use of beta-blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease. Am J Cardiol 103 (2009) 1518-1524
4. Rasmussen J.N., Chong A., and Alter D.A. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 297 (2007) 177-186
5. Gazmararian J.A., Kripalani S., Miller M.J., et al. Factors associated with medication refill adherence in cardiovascular-related diseases. J Gen Intern Med 21 (2006) 1215-1221
6. Dunbar-Jacob J., Bohachick P., Mortimer M.K., et al. Medication adherence in persons with cardiovascular disease. J Cardiovasc Nurs (2003) 209-218
7. Kronish I.M., Reickmann N., Halm E.A., et al. Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. J Gen Intern Med 21 (2006) 1178-1183
8. Horne R., Weinman J., and Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing cognitive representation of medication. Psychology and Health 14 (1999) 1-24
9. McDonald-Miszczak L., Maris P., Fitzgibbon T., et al. A pilot study examining older adults beliefs related to medication adherence. J Aging Health 16 (2004) 591-614
10. Dolder C.R., Lacro J.P., Warren K., et al. Brief evaluation of medication influences and beliefs. J Clin Psycholpharmacol 24 (2004) 404-409
11. Horne R. Assessing perceptions of medication: psychological perspectives. In: Handbook of drug use research methodology. Publ United Kingdom Drug Utilization Research Group ISBN 0 9537011 07.
12. Hoekstra J.W., Pollack Jr. C.V., Roe M.T., et al. Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative. Acad Emerg Med 9 (2002) 1146-1155
13. Melloni C., Alexander K.P., Ou F., et al. Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome. Am J Cardiol 104 (2009) 175-181
14. Kroenke K., Spitzer R.L., and Williams J.B. The PHQ-9, validity of a brief depression severity measure. J Gen Intern Med 16 (2001) 606-613
15. Liang K.Y., and Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika 73 (1986) 13-22
16. Mardby A., Akerlind I., and Jorgensen T. Beliefs about medicines and self-reported adherence among pharmacy clients. Patient Educ Couns 69 (2007) 158-164
17. Phatak H.M., and Thomas J. Relationship between beliefs about medicines and nonadherence to prescribed chronic medications. Ann Pharmacother 40 (2006) 1737-1742
18. Horne R., and Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47 (1999) 555-567
19. Butler J., Arbogast P.G., BeLue R., et al. Outpatient adherence to beta-blocker therapy after acute myocardial infarction. J Am Coll Cardiol (2002) 1589-1595
20. Kramer J.M., Hammill B., Anstrom K.J., et al. National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance. Am Heart J 152 (2006) 454.e1-454.e8
21. Haynes R.B., Ackloo E., Sahota N., et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev (2008) CD000011 10.1002/14651858.CD000011.pub3
22. Gehi A.K., Ali S., Na B., et al. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease. Arch Intern Med 167 (2007) 1798-1803
23. Daugherty S.L., Ho M., Spertus J.A., et al. Association of early follow-up after acute myocardial infarction with higher rates of medication use. Arch Intern Med 168 (2008) 485-491
24. Jackevicius C.A., Li P., and Tu J.V. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation 117 (2008) 1028-1036
25. van Dulmen S., Sluijs E., van Dijk L., et al. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res 7 (2007) 55 10.1186/1472-6963-7-55
26. Murray M.D., Young J., Hoke S., et al. Pharmacist intervention to improve medication adherence in heart failure. Ann Intern Med 146 (2007) 714-725